We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTX icon
13476
PUT
Avalo Therapeutics
AVTX
$1.05B
$18K ﹤0.01%
4
-5
-56% -$30K
EPOW icon
13477
E-Power Inc
EPOW
$20.6M
$18K ﹤0.01%
15,563
-3,267
-17% -$6.7K
IMNN icon
13478
Imunon
IMNN
$6.93M
$18K ﹤0.01%
174
-73
-30% -$11.4K
NERV icon
13479
PUT
Minerva Neurosciences
NERV
$219M
$18K ﹤0.01%
2,875
-7,738
-73% -$72.9K
PIIIW icon
13480
P3 Health Partners Inc Warrant
PIIIW
$153K
$18K ﹤0.01%
17,068
+6,508
+62% +$7.88K
RKDA icon
13481
CALL
Arcadia Biosciences
RKDA
$1.36M
$18K ﹤0.01%
435
-591
-58% -$38.5K
BEDU
13482
DELISTED
Bright Scholar Education Holdings
BEDU
$17K ﹤0.01%
+3,678
New +$33.5K
CDTX
13483
CALL
DELISTED
Cidara Therapeutics
CDTX
$17K ﹤0.01%
680
+110
+19% +$3.42K
TWAV
13484
PUT
TaoWeave Inc
TWAV
$4.92M
$17K ﹤0.01%
+27
New +$25.4K
RMTI icon
13485
Rockwell Medical
RMTI
$29.2M
$17K ﹤0.01%
371
-1,494
-80% -$80K
TMQ
13486
CALL
Trilogy Metals
TMQ
$646M
$17K ﹤0.01%
10,200
-8,000
-44% -$14.7K
UBX
13487
CALL
DELISTED
Unity Biotechnology
UBX
$17K ﹤0.01%
1,150
-580
-34% -$12.7K
BEST
13488
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$17K ﹤0.01%
1,015
+215
+27% +$5.82K
COMS
13489
CALL
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$17K ﹤0.01%
228
+80
+54% +$9.39K
NH
13490
DELISTED
NantHealth, Inc
NH
$17K ﹤0.01%
+1,073
New +$22.7K
ELOX
13491
PUT
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$17K ﹤0.01%
600
-1,515
-72% -$66K
ALNA
13492
DELISTED
Allena Pharmaceuticals
ALNA
$17K ﹤0.01%
29,825
-17,150
-37% -$13.4K
HSTO
13493
DELISTED
Histogen Inc. Common Stock
HSTO
$17K ﹤0.01%
2,560
+838
+49% +$9.58K
LEJU
13494
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$17K ﹤0.01%
1,845
-2,586
-58% -$28.1K
CSLT
13495
PUT
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$17K ﹤0.01%
10,900
+100
+0.9% +$165
BZFDW icon
13496
BuzzFeed Inc Warrant
BZFDW
$624K
$16K ﹤0.01%
31,208
-122,330
-80% -$127K
CLIR icon
13497
CALL
ClearSign Technologies
CLIR
$31.7M
$16K ﹤0.01%
+1,190
New +$19.7K
CLRO icon
13498
ClearOne Inc
CLRO
$14M
$16K ﹤0.01%
+848
New +$20.3K
CNET icon
13499
PUT
ZW Data Action Technologies
CNET
$4.73M
$16K ﹤0.01%
805
-195
-20% -$4.89K
MRKR icon
13500
Marker Therapeutics
MRKR
$19M
$16K ﹤0.01%
1,651
-616
-27% -$8.18K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.